Data Suggests Treatment with FOLOTYN® Reverses Trend of Progressive Resistance Observed in Patients with Drug …
Allos Therapeutics, Inc. today reported results from a retrospective analysis of data from the Company’s pivotal PROPEL trial which suggested that treatment with single-agent FOLOTYN® may result in increased response rates and progression-free survival relative to the immediate prior line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma .
Read more on Business Wire via Yahoo! Finance

Read more...

Exelixis shares fall on cancer drug safety concerns
Shares of Exelixis Inc fell 20 percent on Monday after the company reported data over the weekend showing that its experimental cancer drug caused the deaths of six patients in a clinical trial.
Read more on Reuters via Yahoo! News

Read more...

Sickle cell anemia drug safe and effective for infants and toddlers, adds treatment option, study suggests
New research shows a drug commonly used to treat sickle cell anemia in adults reduces bouts of acute pain and a pneumonia-like illness, cuts hospitalization time and eases other symptoms of the disease in young patients. Results of the randomized, double-blind trial mark a dramatic advance in treatment of children with the inherited blood disorder.
Read more on Science Daily

Read more...

‘Wonderdrug’ keeps breast cancer away Read more...

Herceptin: Long-Term Benefits for Breast Cancer Read more...

FDA grants meeting on Avastin for breast cancer Read more...

The Food and Drug Administration has granted Swiss drugmaker Roche a first-of-a-kind public hearing to defend the effectiveness of its drug Avastin for treating breast cancer, just months after the agency ruled that the drug is ineffective for that use. Read more...

A breast cancer drug that could have benefited thousands of sufferers has been turned down by the Government’s drug rationing body. Read more...

What are the side effects of Truvada, a drug used to treat patients with HIV/AIDS? According to truvada.com, the drug has serious side effects which you should watch out for. Read more...

HIV patients should not combine Invirase (Roche, saquinavir) and Norvir (Abbott Laboratories, ritonavir) because this would cause irregular heartbeats according to the U.S. Food and Drug Administration. The agency recently warned that a combination of these two drugs can trigger irregular heartbeats leading to fainting, lightheadedness and even death Read more...